DEF 14A: Lifeloc Technologies Sets Date for Annual Shareholder Meeting, Outlines Key Proposals
Proxy Statement
Lifeloc Technologies will hold its annual shareholder meeting on June 19, 2024, to elect directors and ratify the appointment of its independent public accountants.
Summary
- Lifeloc Technologies, Inc. will hold its Annual Meeting of Shareholders on June 19, 2024, at 9:00 A.M. Mountain Time, at the company's offices in Wheat Ridge, CO.
- Shareholders of record as of April 30, 2024, are entitled to vote at the meeting.
- The meeting's agenda includes the election of five directors for a one-year term and the ratification of Green Growth CPAs as the company's independent public accountants for the year ending December 31, 2024.
- The board of directors recommends voting in favor of all director nominees and the ratification of Green Growth CPAs.
- The company's outstanding capital stock as of April 30, 2024, consisted of 2,454,116 shares of common stock, each entitled to one vote.
- Shareholder proposals for the 2025 Annual Meeting must be received by February 19, 2025.
- The proxy statement and the Annual Report on Form 10-K for the fiscal year ended December 31, 2023, are available at www.lifeloc.com.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, which is generally neutral in tone. The company is following standard corporate governance procedures, and there are no major red flags. The sentiment is slightly positive due to the company's commitment to ethical and inclusive practices.
Positives
- The board of directors has nominated experienced individuals for election as directors.
- The audit committee is comprised of independent directors.
- The company has a Code of Ethics in place.
- The company encourages a respectful, ethical, diverse, and inclusive work environment.
- The company provides oversight and guidance on compensation, benefits, recruiting, retention, diversity and inclusion, and culture.
Negatives
- The company does not have a standing nominating committee, which could potentially limit the diversity of perspectives considered for board membership.
- The company does not have a standing compensation committee, which could lead to potential conflicts of interest in determining executive compensation.
- The company's anti-hedging policy is not explicit, which could allow employees and directors to hedge against decreases in the market value of the company's equity securities.
Risks
- The proxy statement mentions that the date, time, or location of the Annual Meeting may be changed for reasons related to public health.
- The company's success depends on attracting, retaining, and motivating key employees and associates.
- The company faces risks related to data security, cybersecurity, and information security.
- The company's compensation policies and practices could incentivize short-term risk-taking at the expense of long-term stockholder value.
Future Outlook
The board intends to retain the current leadership structure, with separate roles for the Chairman and Chief Executive Officer, but may combine these offices in the future if it considers such a combination to be in the best interest of the Company.
Management Comments
- The board believes that the separation of the offices of the Chairman and Chief Executive Officer currently functions well and is the optimal leadership structure for the Company.
- Lifeloc remains committed to fostering respectful, ethical, diverse, and inclusive work environment.
- We believe these actions have resulted in a more engaged and effective workforce that is equipped to serve customers in todays rapidly changing environment.
Industry Context
This announcement is a routine part of corporate governance, ensuring shareholders have the opportunity to participate in key decisions and stay informed about the company's performance and direction.
Comparison to Industry Standards
- The director compensation of $1,500 per year is significantly lower than the average compensation for non-employee directors at comparable companies.
- The company's decision to not have a standing nominating committee or compensation committee is less common among larger, publicly traded companies, but may be appropriate given its size and current board composition.
- The company's cybersecurity oversight practices, with quarterly reports to the audit committee and reports to the full board as needed, are in line with industry best practices.
Stakeholder Impact
- Shareholders have the opportunity to elect directors and ratify the appointment of the company's independent public accountants.
- Employees are impacted by the company's human capital management policies and compensation practices.
- The company's performance and governance practices can impact its relationships with customers, suppliers, and creditors.
Next Steps
- Shareholders should review the proxy materials and vote on the proposals.
- The company will hold its Annual Meeting of Shareholders on June 19, 2024.
- The company will report the results of the shareholder vote in a subsequent filing.
Key Dates
| Date | Description |
|---|---|
| August 1989 | Robert D. Greenlee has been a director of the Company since August 1989. |
| July 5, 2011 | Wayne Willkomm, Ph.D., was elected as a director on July 5, 2011. |
| March 21, 2013 | Our Board of Directors adopted the 2013 Stock Option Plan on March 21, 2013. |
| April 1, 2013 | The 2013 Stock Option Plan was approved by our shareholders on April 1, 2013. |
| May 2013 | Michelle Heim joined Lifeloc in May 2013 as a customer service advisor. |
| January 18, 2016 | Wayne Willkomm was designated as the President and Chief Executive Officer. |
| January 18, 2016 | Donald E. Siecke was elected as a director on January 18, 2016. |
| October 6, 2017 | We entered into an amended and restated employment agreement with Dr. Willkomm. |
| March 1, 2020 | Dr. Willkomm was granted fully vested options to purchase 37,500 shares at $3.80 apiece on or before March 1, 2025. |
| September 24, 2020 | Michelle Heim was named our Controller and Chief Accounting Officer on September 24, 2020. |
| March 13, 2021 | Dr. Willkomm was granted fully vested options to purchase 12,500 shares at $3.80 apiece on or before March 13, 2026. |
| December 31, 2021 | All of the 50,000 options granted to Dr. Willkomm expired on December 31, 2021 without vesting. |
| February 23, 2022 | Two employees were granted options to purchase 15,000 shares. |
| October 2, 2023 | We were informed that Gries & Associates, LLC had sold its business to Green Growth CPAs. |
| October 17, 2023 | We engaged and executed an agreement with Green Growth CPAs as our new independent accountant to replace Gries & Associates, LLC. |
| December 31, 2023 | As of December 31, 2023, there were no unvested stock options and there were 123,000 vested stock options outstanding under the Plan. |
| April 20, 2024 | Ages of the board of directors as of April 20, 2024, are provided. |
| April 24, 2024 | The Annual Report for the year ended December 31, 2023, is being mailed to shareholders on or about April 24, 2024. |
| April 24, 2024 | Information regarding common stock owned as of the close of business on April 24, 2024, is provided. |
| April 30, 2024 | Record date for shareholders entitled to vote at the Annual Meeting is April 30, 2024. |
| June 19, 2024 | The Annual Meeting of Shareholders will be held on June 19, 2024. |
| February 19, 2025 | Shareholder proposals for the 2025 Annual Meeting must be received by 5:30 p.m. MST on February 19, 2025. |
Keywords
proxy statement, annual meeting, directors, shareholders, Green Growth CPAs, Lifeloc Technologies, election, ratification, compensation, audit committee, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.